Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Geron Corp. buy BiotechBee

Start price
€2.50
04.01.23 / 60%
Target price
€6.00
31.12.25
Performance (%)
38.38%
End price
€3.46
04.01.23
Summary
This prediction ended on 04.01.23 with a price of €3.46. The BUY prediction by BiotechBee for Geron Corp. saw massive gains of 38.38%. BiotechBee has a follow-up prediction for Geron Corp. where he still thinks Geron Corp. is a Buy. BiotechBee has 60% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Geron Corp. -3.153% -3.153% 37.754%
iShares Core DAX® 4.094% 3.543% 17.404%
iShares Nasdaq 100 1.424% 0.512% 39.212%
iShares Nikkei 225® -1.572% -4.633% 15.731%
iShares S&P 500 1.822% 0.963% 30.396%

According to BiotechBee what are the pros and cons of Geron Corp. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Geron Corp. diskutieren
Prediction Buy
Perf. (%) 38.38%
Target price 6.000
Change
Ends at 31.12.25

Buy mit Kursziel 6,0

In the thread Trading Geron Corp.
Prediction Buy
Perf. (%) 38.38%
Target price 6.000
Change
Ends at 31.12.25

Buy beendet

Current prediction by BiotechBee for Geron Corp.

buy
Geron Corp.

Start price
Target price
Perf. (%)
€2.10
03.03.24
€3.70
31.08.26
68.19%
10.05.24

Could be very worthwhile Investment >20% year

Stopped prediction by BiotechBee for Geron Corp.

buy
Geron Corp.

Start price
Target price
Perf. (%)
€2.88
24.06.23
€4.00
30.04.26
-27.18%
03.03.24

Could be very worthwhile Investment >20% year